Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial (Q27491047)
Jump to navigation
Jump to search
scientific article (publication date: 19 February 2010)
Language | Label | Description | Also known as |
---|---|---|---|
English | Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial |
scientific article (publication date: 19 February 2010) |
Statements
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial (English)
0 references
19 February 2010
0 references
10
0 references
1
0 references
21
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference